Live feed
Filing
SC 13G
SC 13G0001104659-24-038457·RA CAPITAL MANAGEMENT, L.P.
Schedule 13G ownership disclosure
Regulus Therapeutics Inc.
Security class unavailable · CUSIP: 75915K101
Event date: 2024-03-14
Legacy cover-page extraction is best effort and may not include every reporting person.
- Filing-level shares
- 6,250,000
- Percent of class
- 9.5000%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0001104659-24-038457
- Form type
- SC 13G
- Filer
- RA CAPITAL MANAGEMENT, L.P.
- CIK
- CIK 1346824
- Filed
- Mar 25, 2024
- Reporting period
- Mar 14, 2024
- Description
- Schedule 13G beneficial ownership